Literature DB >> 21284691

Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).

J M Ritter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21284691      PMCID： PMC3045541          DOI： 10.1111/j.1365-2125.2011.03918.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  15 in total

1.  Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland.

Authors:  Wan A H Wan Md Adnan; Nur L Zaharan; Kathleen Bennett; Catherine A Wall
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 2.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

3.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

Review 4.  Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.

Authors:  Timothy W R Doulton; Feng J He; Graham A MacGregor
Journal:  Hypertension       Date:  2005-04-04       Impact factor: 10.190

5.  Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.

Authors:  J Ménard; D J Campbell; M Azizi; M F Gonzales
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

6.  Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.

Authors:  G A MacGregor; N D Markandu; S J Smith; G A Sagnella
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

8.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

9.  Renin release regulation during acute renin inhibition in normal volunteers.

Authors:  J Ménard; T T Guyene; G Chatellier; C H Kleinbloesem; P Bernadet
Journal:  Hypertension       Date:  1991-09       Impact factor: 10.190

10.  Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

Authors:  A H van den Meiracker; A J Man in 't Veld; P J Admiraal; H J Ritsema van Eck; F Boomsma; F H Derkx; M A Schalekamp
Journal:  J Hypertens       Date:  1992-08       Impact factor: 4.844
View more
  3 in total

1.  The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.

Authors:  Punnaka Pongpanich; Pasvich Pitakpaiboonkul; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

2.  Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.

Authors:  Jacqueline R Kemp; Hamiyet Unal; Russell Desnoyer; Hong Yue; Anushree Bhatnagar; Sadashiva S Karnik
Journal:  J Mol Cell Cardiol       Date:  2014-06-27       Impact factor: 5.000

3.  Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.

Authors:  Erika Costa de Alvarenga; Matheus de Castro Fonseca; Clarissa Coelho Carvalho; Rodrigo Machado Florentino; Andressa França; Eveline Matias; Paola Bianchi Guimarães; Carolina Batista; Valder Freire; Adriana Karaoglanovic Carmona; João Bosco Pesquero; Ana Maria de Paula; Giselle Foureaux; Maria de Fatima Leite
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.